Global Melanoma Market Size, Status and Forecast 2019-2025

Published On: Jun 2019

Format: PDF

Publisher: QY Research

Pages: 92

Report ID: 1549

Melanoma, also known as malignant melanoma, is a type of cancer that develops from the pigment-containing cells known as melanocytes. Melanomas typically occur in the skin, but may rarely occur in the mouth, intestines, or eye. In women, they most commonly occur on the legs, while in men they are most common on the back. Sometimes they develop from a mole with changes such as an increase in size, irregular edges, change in color, itchiness, or skin breakdown.
Confirmation of the clinical diagnosis is done with a skin biopsy. It is usually followed up with a wider excision of the scar or tumor. Depending on the stage, a sentinel lymph node biopsy may be performed. Treatment of advanced malignant melanoma is performed from a multidisciplinary approach.
In 2018, the global Melanoma market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Melanoma status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Melanoma development in United States, Europe and China.

The key players covered in this study
Amgen
Eristol-Mayers Squibb
Eisai
Roche
Genetech
Janssen Biotech
Pfizer
Novartis
Vical
Ziopharm

Market segment by Type, the product can be split into
Superficial Melanoma
Nodular Melanoma
Lentigo Maglina Melanoma
Acral Lentigious

Market segment by Application, split into
Hospitals
Pharmaceutical Companies
Research Centres
Clinics
Laboratories

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Melanoma status, future forecast, growth opportunity, key market and key players.
To present the Melanoma development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Melanoma are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Melanoma Market Size Growth Rate by Type (2014-2025)
1.4.2 Superficial Melanoma
1.4.3 Nodular Melanoma
1.4.4 Lentigo Maglina Melanoma
1.4.5 Acral Lentigious
1.5 Market by Application
1.5.1 Global Melanoma Market Share by Application (2014-2025)
1.5.2 Hospitals
1.5.3 Pharmaceutical Companies
1.5.4 Research Centres
1.5.5 Clinics
1.5.6 Laboratories
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Melanoma Market Size
2.2 Melanoma Growth Trends by Regions
2.2.1 Melanoma Market Size by Regions (2014-2025)
2.2.2 Melanoma Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Melanoma Market Size by Manufacturers
3.1.1 Global Melanoma Revenue by Manufacturers (2014-2019)
3.1.2 Global Melanoma Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Melanoma Market Concentration Ratio (CR5 and HHI)
3.2 Melanoma Key Players Head office and Area Served
3.3 Key Players Melanoma Product/Solution/Service
3.4 Date of Enter into Melanoma Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Melanoma Market Size by Type (2014-2019)
4.2 Global Melanoma Market Size by Application (2014-2019)

5 United States
5.1 United States Melanoma Market Size (2014-2019)
5.2 Melanoma Key Players in United States
5.3 United States Melanoma Market Size by Type
5.4 United States Melanoma Market Size by Application

6 Europe
6.1 Europe Melanoma Market Size (2014-2019)
6.2 Melanoma Key Players in Europe
6.3 Europe Melanoma Market Size by Type
6.4 Europe Melanoma Market Size by Application

7 China
7.1 China Melanoma Market Size (2014-2019)
7.2 Melanoma Key Players in China
7.3 China Melanoma Market Size by Type
7.4 China Melanoma Market Size by Application

8 Japan
8.1 Japan Melanoma Market Size (2014-2019)
8.2 Melanoma Key Players in Japan
8.3 Japan Melanoma Market Size by Type
8.4 Japan Melanoma Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Melanoma Market Size (2014-2019)
9.2 Melanoma Key Players in Southeast Asia
9.3 Southeast Asia Melanoma Market Size by Type
9.4 Southeast Asia Melanoma Market Size by Application

10 India
10.1 India Melanoma Market Size (2014-2019)
10.2 Melanoma Key Players in India
10.3 India Melanoma Market Size by Type
10.4 India Melanoma Market Size by Application

11 Central & South America
11.1 Central & South America Melanoma Market Size (2014-2019)
11.2 Melanoma Key Players in Central & South America
11.3 Central & South America Melanoma Market Size by Type
11.4 Central & South America Melanoma Market Size by Application

12 International Players Profiles
12.1 Amgen
12.1.1 Amgen Company Details
12.1.2 Company Description and Business Overview
12.1.3 Melanoma Introduction
12.1.4 Amgen Revenue in Melanoma Business (2014-2019)
12.1.5 Amgen Recent Development
12.2 Eristol-Mayers Squibb
12.2.1 Eristol-Mayers Squibb Company Details
12.2.2 Company Description and Business Overview
12.2.3 Melanoma Introduction
12.2.4 Eristol-Mayers Squibb Revenue in Melanoma Business (2014-2019)
12.2.5 Eristol-Mayers Squibb Recent Development
12.3 Eisai
12.3.1 Eisai Company Details
12.3.2 Company Description and Business Overview
12.3.3 Melanoma Introduction
12.3.4 Eisai Revenue in Melanoma Business (2014-2019)
12.3.5 Eisai Recent Development
12.4 Roche
12.4.1 Roche Company Details
12.4.2 Company Description and Business Overview
12.4.3 Melanoma Introduction
12.4.4 Roche Revenue in Melanoma Business (2014-2019)
12.4.5 Roche Recent Development
12.5 Genetech
12.5.1 Genetech Company Details
12.5.2 Company Description and Business Overview
12.5.3 Melanoma Introduction
12.5.4 Genetech Revenue in Melanoma Business (2014-2019)
12.5.5 Genetech Recent Development
12.6 Janssen Biotech
12.6.1 Janssen Biotech Company Details
12.6.2 Company Description and Business Overview
12.6.3 Melanoma Introduction
12.6.4 Janssen Biotech Revenue in Melanoma Business (2014-2019)
12.6.5 Janssen Biotech Recent Development
12.7 Pfizer
12.7.1 Pfizer Company Details
12.7.2 Company Description and Business Overview
12.7.3 Melanoma Introduction
12.7.4 Pfizer Revenue in Melanoma Business (2014-2019)
12.7.5 Pfizer Recent Development
12.8 Novartis
12.8.1 Novartis Company Details
12.8.2 Company Description and Business Overview
12.8.3 Melanoma Introduction
12.8.4 Novartis Revenue in Melanoma Business (2014-2019)
12.8.5 Novartis Recent Development
12.9 Vical
12.9.1 Vical Company Details
12.9.2 Company Description and Business Overview
12.9.3 Melanoma Introduction
12.9.4 Vical Revenue in Melanoma Business (2014-2019)
12.9.5 Vical Recent Development
12.10 Ziopharm
12.10.1 Ziopharm Company Details
12.10.2 Company Description and Business Overview
12.10.3 Melanoma Introduction
12.10.4 Ziopharm Revenue in Melanoma Business (2014-2019)
12.10.5 Ziopharm Recent Development

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst's Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details